i-SENS (investor - Corporate Investor)

See something wrong or missing? Let us know
Offices:Seoul

i-SENS has the vision of the realization of technology to improve human health.
Through its cutting edge biosensor and electrochemistry technology, i-SENS develops, produces and distributes products in order to improve human health.

Through its patent coverage and research power stemming from the work of Dr. Cha and Dr. Nam in the field of biosensor technology, i-SENS continuously develops and launches new and innovative products into the world market.

Average round investment:N/A USD
Average number per year:0.0

Investors with similar profile to i-SENS

Name Criteria
Sweden Håkan Jeppsson
20%
  • Range for average deal size: n/a USD
Spain Alfonso Cortina de Alcocer
20%
  • Range for average deal size: n/a USD
Sweden Alpha Nordic Capital
20%
  • Range for average deal size: n/a USD
AnaCap Financial Partners
20%
  • Range for average deal size: n/a USD
Japan Asahi Kasei
20%
  • Range for average deal size: n/a USD
Denmark Bent Sortsø
20%
  • Range for average deal size: n/a USD
Sweden Bonvent Holdings
20%
  • Range for average deal size: n/a USD
Sweden Bridge140
20%
  • Range for average deal size: n/a USD
Denmark Christian Clausen
20%
  • Range for average deal size: n/a USD
Denmark Christian Eriksen
20%
  • Range for average deal size: n/a USD
Top